TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
918
|
862
|
939 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
496
|
242
|
159 |
EBITDA |
475
|
240
|
159 |
Total assets |
1,492
|
1,464
|
1,735 |
Current assets |
1,492
|
1,464
|
1,735 |
Current liabilities |
16
|
10
|
142 |
Equity capital |
1,437
|
1,410
|
1,545 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
96.3%
![]() |
96.3%
|
89.0% |
Turnover per employee |
918
|
862
|
939 |
Profit as a percentage of turnover |
54.0%
|
28.1%
|
16.9% |
Return on assets (ROA) |
33.2%
|
16.5%
|
9.2% |
Current ratio |
9325.0%
|
14640.0%
|
1221.8% |
Return on equity (ROE) |
34.5%
|
17.2%
|
10.3% |
Change turnover |
52
|
-1
|
-432 |
Change turnover % |
6%
|
0%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.